• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

lncRNA MRAK088388基因敲除抑制哮喘小鼠M2巨噬细胞极化并减轻气道炎症

[Inhibition of M2 macrophage polarization and reduction of airway inflammation in asthmatic mice with lncRNA MRAK088388 knockout].

作者信息

She Weiwei, Sun Tianshou, Long Chengfeng, Chen Meiyu, Chen Xu, Liao Qinxue, Wang Mingdong, Cao Wei

机构信息

Department of Respiratory and Critical Care Medicine, Nanxishan Hospital of Guangxi Zhuang Autonomous Region, Guilin 541002, China. *Corresponding author, E-mail:

Department of Respiratory and Critical Care Medicine, Nanxishan Hospital of Guangxi Zhuang Autonomous Region, Guilin 541002, China.

出版信息

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2023 Sep;39(9):777-786.

PMID:37732572
Abstract

Objective To investigate the long non-coding RNA(lncRNA) MRAK08838 regulates macrophage function to influence the development of asthmatic airway inflammation. Methods MRAK088388 gene knockout (MRAK088388) mouse model was prepared and allergic asthma was induced by dust mite protein Dermatophagoides farinae 1 (Der f1). The mice were sacrificed after 28 days of modeling, and serum was collected to measure IgE and IgG. The FinePointe RC system was used to measure airway hyperresponsiveness and evaluate lung function in mice. Lung tissue was taken for HE staining, and periodic acid-Schiff (PAS) staining was used to evaluate inflammatory infiltration and mucus secretion in mouse lungs. Fluorescence quantitative PCR was used to detect the expression level of lncRNA MRAK08838 in bronchoalveolar lavage fluid (BALF) cells and lung tissue of asthmatic mice. ELISA was used to detect the levels of inflammatory cytokines IFN-γ, IL-4, IL-5, IL-13, IL-10 and IL-17A. Flow cytometry was used to evaluate the phenotype of macrophages in BALF and lung tissue, as well as the proportion of neutrophils, eosinophils, and alveolar macrophages. The changes of the above indicators were detected in mice by adoptive transfer of bone marrow-derived macrophages (BMDM). Results Under the challengle of Der f1, MRAK088388 mice showed reduced allergic airway inflammation, including reduced eosinophils in BALF and reduced production of IgE and IgG1. In addition, Der f1-treated MRAK088388 mice had fewer M2 macrophages than wild-type asthmatic mice. Wild-type mouse BMDM (M0) and Der f1-treated MRAK088388 mice also showed mild inflammatory response. Conclusion Knockout of MRAK088388 alleviates airway inflammation in asthmatic mice by inhibiting M2 polarization of airway macrophages.

摘要

目的 探讨长链非编码RNA(lncRNA)MRAK08838对巨噬细胞功能的调控,以影响哮喘气道炎症的发生发展。方法 制备MRAK08838基因敲除(MRAK08838)小鼠模型,并用尘螨蛋白粉尘螨1(Der f1)诱导过敏性哮喘。造模28天后处死小鼠,收集血清检测IgE和IgG。采用FinePointe RC系统检测小鼠气道高反应性并评估肺功能。取肺组织进行HE染色,采用过碘酸-希夫(PAS)染色评估小鼠肺内炎症浸润和黏液分泌情况。采用荧光定量PCR检测哮喘小鼠支气管肺泡灌洗液(BALF)细胞和肺组织中lncRNA MRAK08838的表达水平。采用ELISA检测炎性细胞因子IFN-γ、IL-4、IL-5、IL-13、IL-10和IL-17A的水平。采用流式细胞术评估BALF和肺组织中巨噬细胞的表型以及中性粒细胞、嗜酸性粒细胞和肺泡巨噬细胞的比例。通过骨髓来源巨噬细胞(BMDM)的过继转移检测小鼠上述指标的变化。结果 在Der f1刺激下,MRAK08838小鼠的过敏性气道炎症减轻,包括BALF中嗜酸性粒细胞减少以及IgE和IgG1产生减少。此外,Der f1处理的MRAK08838小鼠的M2巨噬细胞比野生型哮喘小鼠少。野生型小鼠BMDM(M0)和Der f1处理的MRAK08838小鼠也表现出轻度炎症反应。结论 敲除MRAK088388可通过抑制气道巨噬细胞的M2极化减轻哮喘小鼠的气道炎症。

相似文献

1
[Inhibition of M2 macrophage polarization and reduction of airway inflammation in asthmatic mice with lncRNA MRAK088388 knockout].lncRNA MRAK088388基因敲除抑制哮喘小鼠M2巨噬细胞极化并减轻气道炎症
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2023 Sep;39(9):777-786.
2
LncRNA AK085865 depletion ameliorates asthmatic airway inflammation by modulating macrophage polarization.长链非编码 RNA AK085865 耗竭通过调节巨噬细胞极化改善哮喘气道炎症。
Int Immunopharmacol. 2020 Jun;83:106450. doi: 10.1016/j.intimp.2020.106450. Epub 2020 Apr 1.
3
Gasdermin D silencing alleviates airway inflammation and remodeling in an ovalbumin-induced asthmatic mouse model.Gasdermin D 沉默减轻卵清蛋白诱导的哮喘小鼠模型中的气道炎症和重塑。
Cell Death Dis. 2024 Jun 7;15(6):400. doi: 10.1038/s41419-024-06777-5.
4
Long non-coding RNA NKILA alleviates airway inflammation in asthmatic mice by promoting M2 macrophage polarization and inhibiting the NF-κB pathway.长链非编码 RNA NKILA 通过促进 M2 型巨噬细胞极化和抑制 NF-κB 通路缓解哮喘小鼠的气道炎症。
Biochem Biophys Res Commun. 2021 Sep 24;571:46-52. doi: 10.1016/j.bbrc.2021.07.023. Epub 2021 Jul 21.
5
Iristectorigenin A exerts novel protective properties against airway inflammation and mucus hypersecretion in OVA-induced asthmatic mice: Iristectorigenin A ameliorates asthma phenotype.鸢尾甲素 A 对卵清蛋白诱导的哮喘小鼠气道炎症和黏液过度分泌发挥新的保护作用:鸢尾甲素 A 改善哮喘表型。
Phytomedicine. 2022 Sep;104:154252. doi: 10.1016/j.phymed.2022.154252. Epub 2022 Jun 8.
6
The interleukin-33 receptor ST2 is important for the development of peripheral airway hyperresponsiveness and inflammation in a house dust mite mouse model of asthma.白细胞介素-33受体ST2在哮喘的屋尘螨小鼠模型中,对于外周气道高反应性和炎症的发展至关重要。
Clin Exp Allergy. 2016 Mar;46(3):479-90. doi: 10.1111/cea.12683.
7
TLR2 regulates allergic airway inflammation through NF-κB and MAPK signaling pathways in asthmatic mice.TLR2 通过 NF-κB 和 MAPK 信号通路调节哮喘小鼠的过敏性气道炎症。
Eur Rev Med Pharmacol Sci. 2018 May;22(10):3138-3146. doi: 10.26355/eurrev_201805_15073.
8
miR-146a-5p Attenuates Allergic Airway Inflammation by Inhibiting the NLRP3 Inflammasome Activation in Macrophages.miR-146a-5p 通过抑制巨噬细胞中 NLRP3 炎性小体的激活来减轻过敏性气道炎症。
Int Arch Allergy Immunol. 2022;183(9):919-930. doi: 10.1159/000524718. Epub 2022 Jun 3.
9
Immunomodulatory effects of modified Liu-Wei-Di-Huang-Wan Traditional Chinese medicine on allergic asthmatic mice.加味六味地黄丸对变应性哮喘小鼠的免疫调节作用
Allergy Asthma Clin Immunol. 2023 Apr 26;19(1):35. doi: 10.1186/s13223-023-00792-5.
10
BuShenYiQi Formula strengthens Th1 response and suppresses Th2-Th17 responses in RSV-induced asthma exacerbated mice.补肾益气方增强呼吸道合胞病毒诱导的哮喘加重小鼠的Th1反应并抑制Th2-Th17反应。
J Ethnopharmacol. 2014 May 28;154(1):131-47. doi: 10.1016/j.jep.2014.03.041. Epub 2014 Apr 3.